Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR)
NCT02124031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10241
Last updated 2015-10-23
Summary
The purpose of this study is to evaluate quality of life, degree of disability, treatment patterns and economic impact of hand and knee Osteoarthritis and Rheumatoid Arthritis in Mexico.
Conditions
- Physical Disability
- Joint Function Disorder
- Axis IV Problems Economic
- Compliance Behavior
- Complications; Arthroplasty
Sponsors & Collaborators
- collaborator INDUSTRY
-
Webmedica
collaborator UNKNOWN -
Iniciativa Mexicana de Pacientes con Osteoartritis y Artritis Reumatoide
lead OTHER
Principal Investigators
-
Rolando Espinosa, M. D. · National Institute of Rehabilitation
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-10-31
More Related Trials
-
A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
NCT01878318 ·Status: WITHDRAWN ·Phase: PHASE4
-
An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
NCT01543503 ·Status: COMPLETED
-
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
NCT01462162 ·Status: COMPLETED
-
INCMNSZ - Rheumatoid Arthritis Cohort
NCT03389711 ·Status: UNKNOWN
-
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
NCT00234936 ·Status: COMPLETED ·Phase: PHASE3
-
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors
NCT04821206 ·Status: UNKNOWN
-
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions
NCT03073109 ·Status: COMPLETED
-
Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis
NCT00597623 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.
NCT02011334 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
NCT01893255 ·Status: WITHDRAWN
-
Methotrexate and Metformin in Rheumatoid Arthritis Patients
NCT04196868 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
NCT02309359 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Articular Microbiota in Rheumatoid Arthritis.
NCT04056234 ·Status: COMPLETED
-
A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
NCT01562327 ·Status: COMPLETED
-
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
NCT02046603 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)
NCT01565122 ·Status: COMPLETED
-
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
NCT02287922 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis
NCT01921478 ·Status: COMPLETED
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
NCT01251120 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)
NCT01313520 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
NCT00195663 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis
NCT01834807 ·Status: COMPLETED
-
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
NCT01636843 ·Status: TERMINATED ·Phase: PHASE2
-
An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis
NCT01741688 ·Status: COMPLETED